156 related articles for article (PubMed ID: 31897186)
21. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets.
Qi L; Gao C; Feng F; Zhang T; Yao Y; Wang X; Liu C; Li J; Li J; Sun C
J Cell Biochem; 2019 Nov; 120(11):18956-18966. PubMed ID: 31241205
[TBL] [Abstract][Full Text] [Related]
23. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
Li J; Chen N; Gong X
Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
[TBL] [Abstract][Full Text] [Related]
24. Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma.
Liu J; Nie S; Li S; Meng H; Sun R; Yang J; Cheng W
Ann Transl Med; 2020 Jul; 8(14):868. PubMed ID: 32793712
[TBL] [Abstract][Full Text] [Related]
25. Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Liu Z; Wan Y; Yang M; Qi X; Dong Z; Huang J; Xu J
Cancer Cell Int; 2020; 20():235. PubMed ID: 32536823
[TBL] [Abstract][Full Text] [Related]
26. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive and integrative analysis identifies
He Z; Wang F; Zhang W; Ding J; Ni S
Ann Transl Med; 2019 Nov; 7(22):682. PubMed ID: 31930083
[TBL] [Abstract][Full Text] [Related]
28. Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma.
Huang H; Fu J; Zhang L; Xu J; Li D; Onwuka JU; Zhang D; Zhao L; Sun S; Zhu L; Zheng T; Jia C; Cui B; Zhao Y
Front Oncol; 2021; 11():629860. PubMed ID: 34178621
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.
Zhang R; Zhang TT; Zhai GQ; Guo XY; Qin Y; Gan TQ; Zhang Y; Chen G; Mo WJ; Feng ZB
World J Surg Oncol; 2018 Jun; 16(1):109. PubMed ID: 29914539
[TBL] [Abstract][Full Text] [Related]
30. Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma.
Feng C; Wu J; Yang F; Qiu M; Hu S; Guo S; Wu J; Ying X; Wang J
Oncol Lett; 2018 May; 15(5):6925-6930. PubMed ID: 29725421
[TBL] [Abstract][Full Text] [Related]
31. A four-gene-based methylation signature associated with lymph node metastasis predicts overall survival in lung squamous cell carcinoma.
Deng Y; Liu L; Xiao X; Zhao Y
Genes Genet Syst; 2023 Nov; 98(5):209-219. PubMed ID: 37839873
[TBL] [Abstract][Full Text] [Related]
32. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
33. Whole-genome DNA methylation and DNA methylation-based biomarkers in lung squamous cell carcinoma.
Cai Q; He B; Tu G; Peng W; Shi S; Qian B; Liang Q; Peng S; Tao Y; Wang X
iScience; 2023 Jul; 26(7):107013. PubMed ID: 37389184
[TBL] [Abstract][Full Text] [Related]
34. TRIM58/cg26157385 methylation is associated with eight prognostic genes in lung squamous cell carcinoma.
Zhang W; Cui Q; Qu W; Ding X; Jiang D; Liu H
Oncol Rep; 2018 Jul; 40(1):206-216. PubMed ID: 29749538
[TBL] [Abstract][Full Text] [Related]
35. Identification and Validation of Three-Gene Signature in Lung Squamous Cell Carcinoma by Integrated Transcriptome and Methylation Analysis.
Li G; Wu L; Yu J; Zhai S; Deng H; Wang Q
J Oncol; 2022; 2022():9688040. PubMed ID: 36193204
[TBL] [Abstract][Full Text] [Related]
36. Role of DNA methylation regulation of miR-130b expression in human lung cancer using bioinformatics analysis.
Wang J; Yu XF; OUYang N; Luo Q; Tong J; Chen T; Li J
J Toxicol Environ Health A; 2019; 82(17):935-943. PubMed ID: 31524549
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
38. Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma.
Zhang N; Wang H; Xie Q; Cao H; Wu F; Di Wu DB; Wan Y
Oncol Lett; 2019 Jul; 18(1):169-180. PubMed ID: 31289486
[TBL] [Abstract][Full Text] [Related]
39. Identification of seven-gene signature for prediction of lung squamous cell carcinoma.
Wang Z; Wang Z; Niu X; Liu J; Wang Z; Chen L; Qin B
Onco Targets Ther; 2019; 12():5979-5988. PubMed ID: 31440059
[No Abstract] [Full Text] [Related]
40. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
Gao X; Wu Y; Yu W; Li H
Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
